Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Behavioral Neuroscience|April 1, 1988
Conditional analgesia, defensive freezing, and benzodiazepinesM S Fanselow, F J HelmstetterPhysiology & Behavior|January 1, 1987
Effects of naltrexone on learning and performance of conditional fear-induced freezing and opioid analgesiaF J Helmstetter, M S FanselowBehavioral Neuroscience|October 1, 1987
Strain differences in reversal of conditional analgesia by opioid antagonistsF J Helmstetter, M S FanselowEuropean Journal of Pharmacology|August 9, 1988
Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin testD J Calcagnetti, F J Helmstetter, M S FanselowPharmacology, Biochemistry, and Behavior|July 1, 1987
Quaternary naltrexone reveals the central mediation of conditional opioid analgesiaD J Calcagnetti, F J Helmstetter, M S FanselowBrain Research|March 15, 1988
Peripheral versus intracerebroventricular administration of quaternary naltrexone and the enhancement of Pavlovian conditioningM S Fanselow, D J Calcagnetti, F J HelmstetterJournal of the Experimental Analysis of Behavior|November 1, 1988
Changes in feeding and foraging patterns as an antipredator defensive strategy: a laboratory simulation using aversive stimulation in a closed economyM S Fanselow, L S Lester, F J HelmstetterThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amideM S Fanselow, D J Calcagnetti, F J HelmstetterBehavioral Neuroscience|June 1, 1989
Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266M S Fanselow, D J Calcagnetti, F J HelmstetterPhysiology & Behavior|January 1, 1987
Central and peripheral injection of quaternary antagonist, SR58002C, reduces drinkingD J Calcagnetti, F J Helmstetter, M S FanselowPageof 11